An Evaluation of a Collagen Dressing to Treat Chronic, Stalled Lower-extremity Wounds
NCT03723603 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8
Last updated 2020-03-18
Summary
Patients who meet the inclusion criteria will be provided with fibrillar collagen powder dressing. The powder dressing will be used in accordance with its label. After cleansing the wound by the clinical site staff, the powder is placed directly on the wound, and then the wound will be covered with an appropriate moisture retentive secondary dressing. Patients will visit the clinic twice a week to have the powder re-applied. Wound evaluations will take place once a week at the outpatient clinic, with the intervention lasting up to twelve weeks. Concurrent standard of care, such as compression for venous ulcers, will be provided.
Conditions
- Wound
Interventions
- DEVICE
-
Fibrillar collagen powder dressing
A powder-like fibrillar collagen microsponge composed of Type I porcine dermis collagen. The dressing is a currently marketed, cleared device in the United States, indicated for the management of full and partial thickness wounds: pressure ulcers, diabetic ulcers, caused by mixed vascular origin, venous ulcers, and several other wound types.
Sponsors & Collaborators
-
Medline Industries
lead INDUSTRY
Principal Investigators
-
Windy Cole · Cleveland Foot and Ankle Clinic
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-11-09
- Primary Completion
- 2019-06-04
- Completion
- 2019-07-30
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Clinical Evaluation of the SNaP Wound Care System
NCT01113658 ·Status: WITHDRAWN ·Phase: NA
-
A DERMO-EPIDERMAL AUTOLOGOUS SKIN SUBSTITUTE FOR FURTHER THERAPEUTIC USE
NCT04925323 ·Status: UNKNOWN ·Phase: NA
-
Study to Examine Clinical Performance and Safety of Cutimed® Gelling Fiber in Routine Clinical Practice
NCT05148390 ·Status: COMPLETED
-
LeucoPatch® in Nonhealing Wounds With Exposed Bone or Tendon Study
NCT03370055 ·Status: WITHDRAWN ·Phase: NA
-
A PMCF Investigation on Exuding Chronic Wounds Using Exufiber® as Primary Dressing, and Mepilex® Border Flex/Comfort
NCT04960553 ·Status: TERMINATED ·Phase: NA
-
Prospective, International, Multicenter, Observational Study to Evaluate the Clinical Performance and Safety of a Silicone-coated Transparent Postoperative Dressing
NCT04775316 ·Status: TERMINATED
-
Prospective Evaluation of Silk Fibroin Incision Dressings in ACL Reconstruction
NCT07217613 ·Status: RECRUITING ·Phase: NA
-
Use of Fish Skin Extracellular Matrix (ECM) to Facilitate Chronic Wound Healing
NCT01348581 ·Status: COMPLETED ·Phase: NA
-
Feasibility Study of a Novel Device for Chronic Wounds
NCT00660049 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Exufiber Ag+ and Other Gelling Fibre Dressings
NCT03249909 ·Status: COMPLETED ·Phase: NA
-
Influencing Wound Healing Through the Application of Hyaluronic Acid With Perfluorodecalin and Physalis Angulata Extract After Split Skin Removal From the Thigh - A Study in "Split Wound Design"
NCT03668665 ·Status: WITHDRAWN ·Phase: PHASE3
-
Investigation of the Clinical Performance of Biatain Fiber Ag on Burns
NCT05824026 ·Status: COMPLETED ·Phase: NA
-
Management of Complex Wounds Using a Constant Tension External Tissue Expander
NCT01171521 ·Status: TERMINATED ·Phase: NA
-
Evaluation of a Novel Post-Surgical Dressing
NCT01831596 ·Status: TERMINATED ·Phase: NA
-
Double-layer Artificial Dermal Repair Material Combined With Growth Factors is Used for Exposed Tendon Wounds
NCT05600166 ·Status: UNKNOWN
-
Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars
NCT01858753 ·Status: TERMINATED ·Phase: PHASE2
-
Evaluation of V.A.C. VERAFLO CLEANSE CHOICE™ Dressing Using Normal Saline to Promote Increased Healthy Wound Bed Tissue
NCT04026334 ·Status: TERMINATED ·Phase: NA
-
Benefit of Topical Hemostatic Powder Containing Hydrophilic Polymer With Potassium Ferrate for Hemostasis Following Nail Surgery
NCT04384679 ·Status: WITHDRAWN ·Phase: PHASE4
-
Efficacy and Safety of Silk Fibroin With Bioactive Coating Layer Dressing
NCT02091076 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Chitosan Dressings to Facilitate Safe Effective Debridement of Chronic Wounds & Minimize Wound Bacterial Re-colonization
NCT01035944 ·Status: TERMINATED ·Phase: NA
-
Study of the Effectiveness of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Fibrin to Treat Chronic Wounds
NCT01751282 ·Status: TERMINATED ·Phase: PHASE1
-
Rate of Allergic Contact Dermatitis and Cosmetic Outcomes
NCT06957444 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Clinical Study of Biocellulose Wound Dressing Containing Silk Sericin and PHMB for STSG Donor Sites
NCT02643680 ·Status: UNKNOWN ·Phase: PHASE2
-
Human Tissue Repository for Wound Care
NCT01432054 ·Status: WITHDRAWN
-
Kerecis Fish Skin Grafts With and Without Platelet Rich Plasma (PRP)
NCT05766982 ·Status: WITHDRAWN ·Phase: NA